Twist Bioscience
Manufacturing · California, United States · 501-1,000 Employees
View Company Info for Free
Overview
Headquarters
681 Gateway Blvd, South San Francisco, C...Phone Number
(800) 719-0671Website
www.twistbioscience.comRevenue
$409.5 MillionStock Symbol
TWSTIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
2
2
2
1
1
1
About Twist Bioscience
Twist Bioscience is a synthetic biology company specializing in the large-scale, high-precision manufacturing of synthetic DNA. Using a proprietary silicon-based platform, the company enables researchers in life sciences, medicine, agriculture, and industrial biotechnology to accelerate innovation. Its products and services support advanced genetic research, drug development, and sustainable solutions by delivering reliable, high-quality DNA at speed and scale.Explore more
Twist Bioscience Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Twist Bioscience your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Twist Bioscience, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Twist Bioscience is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Twist Bioscience
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Twist Bioscience had a recent Job posting/layoffs
Earning: See what the market has to say on Twist Bioscience recently announced quarterly report
Product Launch: Get notified when Twist Bioscience launches new products
Funding: Get notified immidiatlly once Twist Bioscience has new funding data
Website visits: Recent activity has been detected on your website
Check if Twist Bioscience has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at Twist Bioscience
Find 2 more new buyers
Compare Similar Companies to Twist Bioscience
Compare insights from companies similar to Twist Bioscience, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Twist Bioscience is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Twist Bioscience is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Twist Bioscience.
Twist Bioscience financials insights
Gather financial insights about Twist Bioscience, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2014
Multiple Rounds
$50.2M
2015
Series C
$37M
2016
Debt
$20M
Series D
$61M
2017
Series E
$60M
2018
Share Placement
$50M
Stock Offering
$69M
2019
Stock Offering
$84.1M
2020
Multiple Rounds
$297.4M
Twist Bioscience Tech Stack
A closer look at the technologies used by Twist Bioscience
See more technologies
Most Recent Scoops
Open Position
Person-Based
Bioengineering, Medical Research
Person-Based
Earnings, Financial Reporting, Finance
Person-Based
Earnings, Finance
Person-Based
Earnings, Events, Finance
Twist Bioscience News & Media
Twist Bioscience (TWST) Rallied as AI and Pharma Drive DNA Demand
Artisan Partners, an investment management company, released its second-quarter 2026 investor letter for the “Artisan Mid Cap Fund”. The letter can be downloaded here. Global equities rebounded sharply in Q2 2026, recovering from March lows as resilient economic data, strong corporate earnings, and continued AI investment improved investor sentiment despite inflation concerns, delayed rate cuts, and […]Twist Bioscience Corporation (TWST) Q3 2026 Earnings Call Transcript
Twist Bioscience Corporation (TWST) Q3 2026 Earnings Call August 3, 2026 8:00 AM EDTCompany ParticipantsAngela Bitting - Chief Corporate Responsibility...Twist Bioscience Q3 Earnings Call Highlights
Twist Bioscience (NASDAQ:TWST) reported fiscal 2026 third-quarter revenue of $118.4 million, up 23% from a year earlier, marking its 14th consecutive quarter of growth. The company raised its full-year revenue outlook and said it remains on track to reach adjusted EBITDA breakeven in the fiscal fourTwist Bioscience Shares Decline Following Quarterly Earnings Miss
Twist Bioscience (NASDAQ:TWST) shares fell 4. 2% in pre-market trading after the synthetic biology company reported fiscal third-quarter results that exceeded revenue expectations but fell short of Wall Street’s earnings forecast.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Twist Bioscience
Sign Up For FreeTo access detailed company insights
Twist Bioscience is a synthetic biology company specializing in the large-scale, high-precision manufacturing of synthetic DNA. Using a proprietary silicon-based platform, the company enables researchers in life sciences, medicine, agriculture, and industrial biotechnology to accelerate innovation. Its products and services support advanced genetic... Read More
